Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells

被引:102
作者
Joncker, Nathalie T. [1 ,2 ]
Raulet, David H. [1 ,2 ]
机构
[1] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94270 USA
[2] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA
关键词
natural killer; MHC class I; missing-self; tolerance; inhibitory Ly49;
D O I
10.1111/j.1600-065X.2008.00658.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Inhibitory receptors specific for major histocompatibility complex (MHC) class I molecules govern the capacity of natural killer (NK) cells to attack class I-deficient cells ('missing-self recognition'). These receptors are expressed stochastically, such that the panel of expressed receptors varies between NK cells. This review addresses how the activity of NK cells is coordinated in the face of this variation to achieve a repertoire that is self-tolerant and optimally reactive with diseased cells. Recent studies show that NK cells arise in normal animals or humans that lack any known inhibitory receptors specific for self-MHC class I. These NK cells exhibit self-tolerance and exhibit functional hyporesponsiveness to stimulation through various activating receptors. Evidence suggests that hyporesponsiveness is induced because these NK cells cannot engage inhibitory MHC class I molecules and are therefore persistently over-stimulated by normal cells in the environment. Finally, we discuss evidence that hyporesponsiveness is a quantitative trait that varies depending on the balance of signals encountered by developing NK cells. Thus, a tuning process determines the functional set-point of NK cells, providing a basis for discriminating self from missing-self, and at the same time endowing each NK cell with the highest inherent responsiveness compatible with self-tolerance.
引用
收藏
页码:85 / 97
页数:13
相关论文
共 93 条
  • [21] Dorfman JR, 1997, J IMMUNOL, V159, P5219
  • [22] A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules
    Fernandez, NC
    Treiner, E
    Vance, RE
    Jamieson, AM
    Lemieux, S
    Raulet, DH
    [J]. BLOOD, 2005, 105 (11) : 4416 - 4423
  • [23] George TC, 1999, J IMMUNOL, V162, P2035
  • [24] CD4+ CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-β-dependent manner
    Ghiringhelli, F
    Ménard, C
    Terme, M
    Flament, C
    Taieb, J
    Chaput, N
    Puig, PE
    Novault, S
    Escudier, B
    Vivier, E
    Lecesne, A
    Robert, C
    Blay, JY
    Bernard, J
    Caillat-Zucman, S
    Freitas, A
    Tursz, T
    Wagner-Ballon, O
    Capron, C
    Vainchencker, W
    Martin, F
    Zitvogel, L
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (08) : 1075 - 1085
  • [25] Grigoriadou K, 1999, EUR J IMMUNOL, V29, P3683, DOI 10.1002/(SICI)1521-4141(199911)29:11<3683::AID-IMMU3683>3.0.CO
  • [26] 2-B
  • [27] Cutting edge:: Identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1
    Gründemann, C
    Bauer, M
    Schweier, O
    von Oppen, N
    Lässing, U
    Saudan, P
    Becker, KF
    Karp, K
    Hanke, T
    Bachmann, MF
    Pircher, H
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 176 (03) : 1311 - 1315
  • [28] Hanke T, 1998, EUR J IMMUNOL, V28, P4409, DOI 10.1002/(SICI)1521-4141(199812)28:12<4409::AID-IMMU4409>3.0.CO
  • [29] 2-3
  • [30] Hanke T, 2001, EUR J IMMUNOL, V31, P3370, DOI 10.1002/1521-4141(200111)31:11<3370::AID-IMMU3370>3.0.CO